Was the FDA aware of the cancer link when it approved the VeriChip for human use?
Based on the available evidence, it appears the FDA was not aware of the cancer studies. When the FDA approved the VeriChip for human use in October 2004, it relied on the company to disclose any risks associated with the device. 35 It was VeriChip’s responsibility to alert the FDA to the cancer findings and provide copies of the studies to the FDA for review. However, since VeriChip senior executives have publicly stated that neither they nor the company knew about the studies at that time, they could not possibly have provided them to the FDA. VeriChip’s CEO Scott Silverman and its chief medical officer Dr. Jonathan Musher have both stated that they had no knowledge of the cancer studies before the Associated Press broke the story in September 2007. In a written statement to the Associated Press, Mr. Silverman stated that his company was “not aware of any studies that have resulted in malignant tumors in laboratory rats, mice and certainly not dogs or cats.” 36 He later reaffirmed th
Related Questions
- Did the VeriChip Corporation (then operating as "Applied Digital Solutions") intentionally fail to provide the cancer studies to the FDA?
- Is Immunocal approved by the FDA for the treatment of cancer, chronic fatigue, auto-immune, and glutathione deficiency diseases?
- Has the FDA been asked whether it reviewed the cancer studies before it approved the VeriChip?
